Work

Preclinical evidence for the use of anti-TROP-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer

Year: 2024

Type: article

Source: European Urology

DOI: 10.1016/s0302-2838(24)01114-x

Authors: R. Weiten, M. Niemann, E. Below, L.L. Friker, D.J. Ralser, M. Toma, G. Kristiansen, O. Hahn, S. Zechel, V. Grünwald, T. Bald, J. Siewert, T. Pietsch, M. Ritter, M. Hölzel, M. Eckstein, A. Alajati, P. Krausewitz, N. Klümper

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4392765253

FWCI:

Cites:

Cited by:

Related to: 10